Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-10-01 Sale | 2021-10-05 5:01 pm | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 50,000 | $4.89 | $244,500 | 49,587 (Direct) | View |
| 2021-09-20 Sale | 2021-09-22 5:00 pm | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 25,000 | $4.97 | $124,250 | 99,587 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-10 Option Award | 2022-03-14 5:01 pm | N/A 2032-03-10 | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 124,700 | $0 | 143,700 (Direct) | View |
| 2021-10-01 Exercise | 2021-10-05 5:01 pm | N/A 2026-09-14 | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 50,000 | $0 | 49,587 (Direct) | View |
| 2021-10-01 Exercise | 2021-10-05 5:01 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 50,000 | $0.92 | 49,587 (Direct) | View |
| 2021-09-20 Exercise | 2021-09-22 5:00 pm | N/A 2026-09-14 | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 25,000 | $0 | 99,587 (Direct) | View |
| 2021-09-20 Exercise | 2021-09-22 5:00 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 25,000 | $0.92 | 99,587 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 7:08 pm | N/A 2031-02-25 | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 101,000 | $0 | 101,000 (Direct) | View |
| 2020-03-24 Option Award | 2020-03-26 5:01 pm | N/A 2030-03-24 | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 31,600 | $0 | 31,600 (Direct) | View |
| 2019-10-07 Option Award | 2019-10-07 7:19 pm | N/A 2029-10-02 | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 77,630 | $0 | 77,630 (Direct) | View |
Ownership | 2019-10-02 6:09 pm | N/A 2026-09-14 | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 0 | $0 | 262,827 (Direct) | View |